Regenerative Patch Technologies LLC (RPT) is a California based biotechnology company focused on the development of cell-based implant technology for the treatment of retinal diseases.

The technology to produce the CPCB-RPE1 implant is exclusively licensed to RPT from the University of Southern California, the California Institute of Technology and UC at Santa Barbara.